http://DUB-ICONWCS-01/news-events/news//xmlNet revenues for the quarter were $224 million, representing a 2% increase over net revenues of $220 million for the same quarter last year. On a constant currency basis revenue grew by 3.1%. Year-to-date, net revenues were $443 million, representing a 1% increase over the same period last year.http://www.icondevsolutions.com/news-events/news/icon-reports-revenues-up-/index.xmlTue, 27 Jul 2010 10:33:07 GMTICON today announced the official opening of a purpose-built clinical pharmacology unit within the Central Manchester University Hospitals Foundation Trust (CMFT) campus in Manchester, UK. Initial studies in the unit utilising translational medicine methodologies to expedite drug development projects began in June, and already 110 volunteers have participated in studies therehttp://www.icondevsolutions.com/news-events/news/icon-opens-purpose-built-/index.xmlFri, 16 Jul 2010 09:05:00 GMTtoday announced the appointment of Jonathan M Fishbein, M.D. as Vice President and Global Head for the Infectious Disease & Vaccines Therapeutic Area Group at ICON Clinical Research. Dr. Fishbein, who has extensive experience in the planning and execution of clinical research in a broad range of therapeutic areas, will oversee the growth and management of the infectious disease portfoliohttp://www.icondevsolutions.com/news-events/news/icon-clinical-research-an/index.xmlWed, 14 Jul 2010 10:20:40 GMTDublin, Ireland, 30th June 2010: ICON Central Laboratories - a division of ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries – today announced the opening of a new laboratory facility in Tianjin, China, in partnership with Fountain Medical Development Ltd (FMD).http://www.icondevsolutions.com/news-events/news/icon-and-fountain-medical/index.xmlWed, 30 Jun 2010 09:00:00 GMTBMS today announced that it has signed agreements with ICON and PAREXEL, two leading providers of clinical development services to the biopharmaceutical industry, for joint strategic, operational and capability support of the company’s clinical development program.http://www.icondevsolutions.com/news-events/news/bristol-myers-squibb-sign/index.xmlMon, 14 Jun 2010 12:16:31 GMTICON plc today announced the launch of the ICOLabs™ Medical Review Application (IMRA) an innovative web based laboratory application that enables more efficient use of medical monitoring time.http://www.icondevsolutions.com/news-events/news/icon-launches-innovative-/index.xmlThu, 10 Jun 2010 09:00:00 GMTICON today announced that it has acquired Timaq Medical Imaging, a leading European provider of advanced imaging services to pharmaceutical and biotech firms.http://www.icondevsolutions.com/news-events/news/icon-acquires-timaq-medic/index.xmlMon, 24 May 2010 09:01:10 GMTFirst quarter net revenues were $219 million. Income from operations was $26.8 million. Operating margin of 12.2%. Diluted earnings per share increased by 2 cent on last year to 37c. Net new business wins in the quarter of $265m, representing a book-to-bill ratio of 1.2. Dublin, Ireland, April 27, 2010 – ICON (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter ended March 31, 2010. Net revenues for the quart http://www.icondevsolutions.com/news-events/news/icon-reports-solid-first-/index.xmlTue, 27 Apr 2010 11:07:59 GMTICON and Tigermed Consulting, a leader in the provision of clinical drug development services in China, today announced that they have signed an alliance agreement. Through this agreement, ICON and Tigermed will collaborate to offer pharmaceutical and biotechnology clients better access to Chinese patients, utilising the global reach and experience of the ICON organisation, complemented by Tigermed’s in depth knowledge of the Chinese drug development landscape and geographic coverage in China. http://www.icondevsolutions.com/news-events/news/icon-and-tigermed-sign-al/index.xmlTue, 06 Apr 2010 17:53:06 GMTICON has expanded its footprint in Asia-Pacific with the opening of an office in Manila, Philippines. This announcement follows the recent expansion of ICON’s operations in Seoul, Korea and ICON Central Laboratories’ move to a larger laboratory facility in Singapore. http://www.icondevsolutions.com/news-events/news/icon-continues-asia-pacif/index.xmlTue, 16 Mar 2010 09:53:45 GMTICON reports Full-Year 2009 EPS growth of 18% and announces Revenue and EPS Guidance for 2010http://www.icondevsolutions.com/news-events/news/icon-reports-full-year-20-2/index.xmlThu, 25 Feb 2010 12:35:47 GMTMr. Bob Scott-Edwards has retired from the position of President, ICON Central Laboratories. Mr. Tom O’Leary, previously Senior Vice President and Global Head of Data Management, ICON Clinical Research, has succeeded Mr. Scott-Edwards. http://www.icondevsolutions.com/news-events/news/icon-announces-retirement/index.xmlWed, 13 Jan 2010 12:36:34 GMThttp://www.icondevsolutions.com/news-events/news/dr.-john-climax-announces/index.xmlThu, 17 Dec 2009 12:34:41 GMTICON has expanded its European Central Laboratory in Dublin. The newly-designed 41,000 sq ft (3,800m²) facility, which is three times the size of the previous laboratory, provides centralised testing and site support services to clinical investigators in over 70 countries throughout Europe, Middle East and Africa. http://www.icondevsolutions.com/news-events/news/icon-central-laboratories-6/index.xmlMon, 14 Dec 2009 10:29:15 GMTThe unit is the first deliverable from a collaborative agreement between ICON and the Central Manchester University Hospitals Foundation (CMFT) to develop purpose-built translational medicine facilities on the newly-developed Manchester Royal Infirmary (MRI) campus.http://www.icondevsolutions.com/news-events/news/icon-announces-details-of/index.xmlMon, 07 Dec 2009 10:25:39 GMTAward-winning poster was co-authored by representatives from ICON Clinical Research and ICON Medical Imaging. http://www.icondevsolutions.com/news-events/news/icon-wins-best-poster-awa/index.xmlFri, 13 Nov 2009 15:00:24 GMThttp://www.icondevsolutions.com/news-events/news/icon-medical-imaging-help/index.xmlMon, 09 Nov 2009 12:30:08 GMThttp://www.icondevsolutions.com/news-events/news/icon-reports-14-increase-/icon-selected-by-lilly-to/index.xmlTue, 03 Nov 2009 18:27:49 GMTICON has signed an extension to its strategic agreement with Eli Lilly and Company to manage the company’s clinical data management outside the US. This extension means that ICON will now also manage Lilly’s needs in Japan in addition to those in Europe, Canada, Latin America, Australia and Asia.http://www.icondevsolutions.com/news-events/news/icon-selected-by-lilly-to/index.xmlMon, 02 Nov 2009 12:28:13 GMTa global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for its third quarter ended September 30, 2009.http://www.icondevsolutions.com/news-events/news/icon-reports-14-increase-/index.xmlWed, 21 Oct 2009 11:07:13 GMT